Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer

被引：0
|
作者：
Tarantino, Paolo
Lee, Do
Foldi, Julia
Soulos, Pamela R.
Gross, Cary Philip
Grinda, Thomas
Winer, Eric P.
Lin, Nancy U.
Krop, Ian E.
Tolaney, Sara M.
Lustberg, Maryam B.
Sammons, Sarah L.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Yale Sch Med, New Haven, CT USA
[3] UPMC, Pittsburgh, PA USA
[4] Yale Canc Ctr, New Haven, CT USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1077
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Trastuzumab deruxtecan (T-DXd) sensitivity in various levels of HER2 expressing gastric cancer cells.
    Yu, Seo Young
    Park, Juin
    Kwon, Woo Sun
    Jeong, Inhye
    Kang, Sun Kyoung
    Bae, Hyun Joo
    Kim, Tae Soo
    Chung, Hyun Cheol
    Rha, Sun Young
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Real-life experience of trastuzumab deruxtecan (T-DXd) in patients with heavily pretreated HER2 positive advanced breast cancer: A retrospective single institution study
    Vosoughi, Elham
    Nafissi, Nellie
    Mahadevan, Aditya
    Lee, Seungshin
    Parajuli, Kritisha
    Rijal, Nejina
    Parajuli, Ritesh
    Mehta, Rita S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Overcoming trastuzumab resistance using trastuzumab deruxtecan (T-DXd), a HER2 targeting antibody drug conjugate, in HER2 amplified gastric cancer.
    Park, Juin
    Jeong, Inhye
    Kang, Sun Kyoung
    Yu, Seo Young
    Kwon, Woo Sun
    Kim, Tae Soo
    Hwang, Jihyun
    Chung, Hyun Cheol
    Rha, Sun Young
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Trastuzumab Deruxtecan (T-DXd)-associated interstitial lung disease (ILD) in a large real- world French cohort of patients with HER2-driven breast cancer and other malignancies
    Elu, Lana
    Canellas, Anthony
    Du Rusquec, Pauline
    Benderra, Marc Antoine
    Drouin, Leonor
    Cojean-Zelek, Isabelle
    Vozy, Aurore
    Assaf, Elias
    Benmaziane, Asmahane
    Medioni, Jacques
    Cohen, Romain
    Zelek, Laurent
    Wislez, Marie
    Gligorov, Jacques
    Brillet, Pierre Yves
    Girard, Nicolas
    Bihan, Kevin
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [25] Trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer with brain metastases: A subgroup analysis of the DESTINY-Breast01 trial.
    Jerusalem, Guy Heinrich Maria
    Park, Yeon Hee
    Yamashita, Toshinari
    Hurvitz, Sara A.
    Modi, Shanu
    Andre, Fabrice
    Krop, Ian E.
    Gonzalez, Xavier
    Hall, Peter S.
    You, Benoit
    Saura, Cristina
    Kim, Sung-Bae
    Osborne, Cynthia R. C.
    Sagara, Yasuaki
    Tokunaga, Eriko
    Liu, Yali
    Cathcart, Jillian
    Lee, Caleb C.
    Perrin, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] HER2 expression-independent antitumor effect of trastuzumab deruxtecan (T-DXd) on pediatric solid tumors
    Takasugi, Nao
    Deguchi, Takao
    Kato, Motohiro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
    Wolff, Antonio C.
    Mcshane, Lisa M.
    Allison, Kimberly H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 829 - 831
  • [28] Single institute experience of treatment for metastatic HER2 positive breast cancer patients with trastuzumab deruxtecan
    Kojima, Yasuyuki
    Tsugawa, Koichiro
    ANNALS OF ONCOLOGY, 2021, 32 : S338 - S338
  • [29] Pulmonary toxicities in patients (pts) with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd): The Mayo Clinic experience
    Hoppenworth, Jenna
    Premji, Sarah
    Smith, Deanne R.
    Taraba, Jodi L.
    Hobday, Timothy J.
    Peethambaram, Prema P.
    Carroll, Jamie
    Ruddy, Kathryn Jean
    O'Sullivan, Ciara Catherine
    Tevaarwerk, Amye Juliet
    Choong, Grace Mei Yee
    Cathcart-Rake, Elizabeth Jane
    Yadav, Siddhartha
    Ellsworth, Lisa
    Rao, Rohit
    Egan, Ashley
    Haddad, Tufia C.
    Goetz, Matthew P.
    Giridhar, Karthik
    Leon-Ferre, Roberto Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
    Moser, Sarah Sharman
    Apter, Lior
    Livnat, Idit
    Ginsburg, Roni
    Yarden, Adva
    Drori, Michal
    Drizon, Anat
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 105 - 116
12345